How to find good-value stocks that could help you make a million

I reckon valuation is an important step towards finding millionaire-maker shares. Here’s how.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

I reckon one of the best chances of finding shares that go on to perform well is to focus on the underlying quality of the business. But after you’ve done that, you can increase the probability of a successful investment outcome by looking for good value as well.

Super-performing investor Warren Buffett once said, “Whether we’re talking about socks or stocks, I like buying quality merchandise when it is marked down.”

Cheap stocks tend to outperform expensive stocks for their shareholders – not always, but studies have shown that it happens often enough to make hunting for good value worth all the effort.

Valuation must-have tools

We can use several indicators to uncover value. One of the most well-known is the price-to-earnings ratio, or earnings multiple as it is sometimes called. It divides the share price by the figure for annual earnings per share to come up with a single number, such as 12, for example. The higher the number, the more expensive the stock when measured against earnings.

Then there’s the dividend yield, which divides the annual dividend per share figure by the share price. That calculation usually comes up with a decimal fraction and if you multiply it by 100 you can express it as a percentage, such as 5%, for example. The higher the percentage, the cheaper the stock compared to the dividend.

Those two measures are straightforward and universal to all stocks. Others require greater interpretation, such as the price-to-sales ratio. To find that, you just divide the market capitalisation by the annual revenue figure. Tesco, for example, is running at about 0.35. However, supermarkets shift loads of stock and make a tiny profit on each item, so that figure doesn’t necessarily mean the shares are selling cheap.

Indeed, firms in other sectors can look quite different when it comes to the price-to-sales ratio. BT, for example, throws out a figure of about 0.83 right now, but BT arguably looks cheaper than Tesco when measured against other indicators. And GlaxoSmithKline has a figure around 2.6. I reckon it’s important to compare the price-to-sales rating of a firm against other companies in the same sector and to use the measure in conjunction with other value indicators.

It’s a similar story with indicators such as the price-to-asset (or book) value and price-to-free cash flow. They are useful tools, but not in isolation and not without comparison.

Avoiding low-valuation losers

Valuation is an important step in finding shares that will go on to perform well for shareholders, but don’t get carried away with it. I reckon it always pays to remember that we are looking for good quality stocks selling as cheaply as possible and not just cheap stocks.

It’s worth bearing in mind that companies with low-quality businesses, or those in a distressed state, often throw up the cheapest-looking valuation indicators. But you wouldn’t want to touch them with a bargepole, in my view.

Quality stocks will probably never show you very low valuation measures, but they will likely appear at fair prices from time to time, and those are the best times to pounce if they are to help you make a million.

Kevin Godbold has no position in any share mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended Tesco. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Middle-aged white man pulling an aggrieved face while looking at a screen
Market Movers

Down 7%! Why on earth are Imperial Brands shares plummeting today?

Imperial Brands shares are in freefall after a negative reception to fresh trading news. Is the party finally over for…

Read more »

Rear View Of Woman Holding Man Hand during travel in cappadocia
Investing Articles

With a P/E under 7, this value stock looks far too cheap at 101p

This writer reckons value stock Hostelworld (LSE:HSW) looks dirt-cheap as it gets dividends flowing again and builds a social travel…

Read more »

Thoughtful man using his phone while riding on a train and looking through the window
Investing For Beginners

Down 30% in 6 months, I think there’s a big catch to this insanely cheap stock

Jon Smith talks through why careful research is needed when trying to assess if a cheap stock is worth buying…

Read more »

Investing Articles

£5,000 invested in National Grid shares 5 years ago is now worth…

Andrew Mackie takes a closer look at National Grid shares and why short-term market weakness could be missing a powerful…

Read more »

DIVIDEND YIELD text written on a notebook with chart
Investing Articles

How big does an ISA need to be to aim for a £1,500 monthly second income?

Harvey Jones shows how building a balanced portfolio of FTSE 100 dividend stocks can produce a high-and-rising second income in…

Read more »

Person holding magnifying glass over important document, reading the small print
Investing Articles

£20,000 invested in BP shares 1 year ago is now worth…

BP shares have rocketed in the past 12 months, yet analysts think the real growth story is only just beginning,…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

A 6.8% forecast yield! 1 often-overlooked FTSE 100 income stock to buy today?

This income stock offers a high forecast yield and strengthening momentum, yet many investors overlook it — creating a rare…

Read more »

GSK scientist holding lab syringe
Investing Articles

GSK’s share price is under £22, but with a ‘fair value’ much higher, is it time for me to buy more right now? 

GSK’s share price rose over the last year, but a huge gap remains between its price and fair value —…

Read more »